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Summary
Background The annual number of hospital admissions and in-hospital deaths due to severe acute lower respiratory 
infections (ALRI) in young children worldwide is unknown. We aimed to estimate the incidence of admissions and 
deaths for such infections in children younger than 5 years in 2010.
Methods We estimated the incidence of admissions for severe and very severe ALRI in children younger than 5 years, 
stratiﬁ ed by age and region, with data from a systematic review of studies published between Jan 1, 1990, and March 
31, 2012, and from 28 unpublished population-based studies. We applied these incidence estimates to population 
estimates for 2010, to calculate the global and regional burden in children admitted with severe ALRI in that year. We 
estimated in-hospital mortality due to severe and very severe ALRI by combining incidence estimates with case 
fatality ratios from hospital-based studies.
Findings We identiﬁ ed 89 eligible studies and estimated that in 2010, 11·9 million (95% CI 10·3–13·9 million) 
episodes of severe and 3·0 million (2·1–4·2 million) episodes of very severe ALRI resulted in hospital admissions in 
young children worldwide. Incidence was higher in boys than in girls, the sex disparity being greatest in South Asian 
studies. On the basis of data from 37 hospital studies reporting case fatality ratios for severe ALRI, we estimated that 
roughly 265 000 (95% CI 160 000–450 000) in-hospital deaths took place in young children, with 99% of these deaths 
in developing countries. Therefore, the data suggest that although 62% of children with severe ALRI are treated in 
hospitals, 81% of deaths happen outside hospitals.
Interpretation Severe ALRI is a substantial burden on health services worldwide and a major cause of hospital referral 
and admission in young children. Improved hospital access and reduced inequities, such as those related to sex and 
rural status, could substantially decrease mortality related to such infection. Community-based management of 
severe disease could be an important complementary strategy to reduce pneumonia mortality and health inequities.
Funding WHO.
Introduction
Acute lower respiratory infections (ALRI), such as 
pneumonia and bronchiolitis, are a leading cause of 
morbidity and mortality in young children. In 2010, 
1·4 million children died because of such infections,1 
resulting in a substantial burden on the health-care 
system. No systematically established global estimates 
have been made of the incidence of hospital admissions 
for severe ALRI in children younger than 5 years. Rudan2 
estimated that worldwide, 7–13% of 156 million yearly 
pneumonia cases might progress to severe disease and 
warrant admission. However, these preliminary esti-
mates were based on ﬁ ndings from only 28 community-
based studies of disease incidence, six of which estimated 
the proportion of severe episodes, and these had variable 
case ascertainment.
We were aware of additional high-quality data for 
incidence of and mortality from admissions for severe 
ALRI. These data were from published and un pub lished 
hospital-based studies with passive case ascertainment—
ie, children who reported to the health facility. Therefore, 
we formed a Severe ALRI Working Group, a consortium 
of leading researchers in childhood pneumonia working 
mainly in developing countries, to estimate the incidence 
of hospital admissions and in-hospital deaths due to 
severe ALRI in children younger than 5 years in 2010, 
worldwide and for six WHO regions. Furthermore, we 
examined how these estimates varied by severity of 
episode, by sex, by distance from the hospital, and in the 
period 2008–10 during the inﬂ uenza A H1N1 pandemic.
Methods
Search strategy and selection criteria
We undertook a systematic literature review with various 
search terms (appendix pp 4–6), hand searched online 
journals, and scanned the reference lists of identiﬁ ed 
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citations. We searched Medline (Ovid), Embase, 
CINAHL, Global Health, Web of Science, WHOLIS, 
LILACS, IndMed, SIGLE for studies published between 
Jan 1, 1990, and March 31, 2012. We also searched three 
Chinese language databases: China National Knowledge 
Infrastructure, Wanfang Data, and Chongqing VIP for 
studies published in Chinese.
We included studies reporting data for hospital admis-
sion for ALRI and severe ALRI in children younger than 
5 years, with data for at least 12 consecutive months, and 
reporting incidence or mortality for at least the ﬁ rst year of 
life. Although we assessed studies reporting incidence 
estimates, we included only those with well deﬁ ned 
catchment populations or estimations of the population at 
risk. We excluded studies in which the case deﬁ nition was 
not clearly deﬁ ned or not consistently applied; description 
of the methods for estimation of the denominator 
population was not clear; only cause-speciﬁ c ALRI 
incidence or mortality were reported; only incidence or 
mortality estimates for ALRI conﬁ rmed by chest 
radiograph were reported; those in which incidence or 
mortality were estimated with modelling techniques; or 
those reporting data by community-based case ascertain-
ment. We applied no language or publication restrictions. 
Two investigators (HN and PH) did the search in English 
language databases and extracted data. Any disagreements 
were resolved after discussion. One investigator (JSFZ) 
whose ﬁ rst language was Chinese undertook searches and 
data abstraction from Chinese language databases and 
validated identiﬁ ed studies in direct discussion with HN. 
Unpublished studies were identiﬁ ed in meetings of the 
Severe ALRI Working Group.
The working group agreed on an approach for data 
analysis and interpretation and formulated common case 
deﬁ nitions. The group either reanalysed data from their 
already published work with these case deﬁ nitions or 
shared hitherto unpublished data from ongoing studies. 
This method resulted in analysis of substantial unpub-
lished data, which supplemented data from review of 
published studies (appendix pp 14–16).
Deﬁ nitions
Most investigators used modiﬁ ed versions of WHO case 
deﬁ nitions for severe pneumonia (appendix pp 17–26).3 
We used the terms severe and very severe ALRI because 
many young children present with bronchiolitis, which 
can be clinically indistinguishable from pneumonia. We 
decided that children with ALRI denoted by cough or 
diﬃ  culty breathing with increased respiratory rate for 
age, with or without indrawing of the chest wall who 
were admitted at the discretion of the attending physician 
should be referred to as having severe ALRI. We deﬁ ned 
very severe ALRI as severe ALRI with hypoxaemia, or 
WHO Integrated Management of Childhood Illness 
danger signs, or both. Because data for hypoxaemia were 
limited to health facilities where pulse oximetry was 
available, we included studies reporting data for children 
admitted with severe ALRI and any of the danger signs3 
in the category of very severe ALRI (appendix pp 27–30). 
We recognised that children admitted with very severe 
ALRI would have a more life-threatening illness and 
regarded these patients as a subset of those with severe 
ALRI. We designated countries as industrialised or 
developing on the basis of UNICEF’s classiﬁ cation in 
The State of the World’s Children 2012 report. The child 
population estimates for 2010 are as in the UN Population 
Division’s database, World Population Pro spects: the 
2010 revision.
Data imputation
For studies that did not report disease incidence for the 
full age range (ie, 0–59 months), we used imputation to 
calculate missing data by use of the median incidence 
rate ratio (appendix pp 7–8).4,5 We did a sensitivity analysis 
with unimputed data and noted that the ﬁ nal estimates 
did not diﬀ er signiﬁ cantly. If the duration of the study 
exceeded 12 months, but was not in exact multiples of 
1 year, we calculated and reported the annualised 
incidence by adjusting for the population at risk.
Statistical analysis
We did a meta-analysis of data for disease incidence 
and case-fatality ratio and report pooled estimates 
and 95% CIs. We used the random eﬀ ects model 
(DerSimonian-Laird method) because of signiﬁ cant 
heterogeneity in the data (I²>80%, p<0·0005).6 Because 
HIV is a major risk factor for admission for severe ALRI, 
and the prevalence of HIV in children younger than 
5 years has decreased substantially and access to highly 
active antiretroviral treatment has increased greatly in 
South Africa since 2002 (median year for the study from 
Soweto, South Africa),7 we adjusted the incidence 
(appendix pp 17–26) taking into consideration both 
determinants and used the adjusted rates when under-
taking the meta-analysis (appendix pp 9–11). We used 
data for the period Jan 1, 1981, to Dec 31, 2010, and 
estimated the incidence for industrialised and developing 
countries and for the six WHO regions, and applied 
these estimates to children younger than 5 years in 2010. 
We used two approaches to estimate the probable 
number of children with episodes of severe ALRI who 
were not admitted and hence (by combining those 
estimates with our hospital estimates), the total number 
of severe cases in developing countries in 2010. First, we 
used data for health-care use (in chil dren with reported 
signs of pneumonia) from Demographic Health Survey 
(DHS) and Multi Indicator Cluster Survey (MICS) 
databases from 81 surveys from developing countries as 
a proxy for the proportion of children with severe ALRI 
who sought hospital care.
For the second approach we used data from four 
hospital studies that recorded all admissions for severe 
ALRI within the setting of community-based active 
surveillance of all episodes  of ALRI and severe ALRI 
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(on the basis of WHO Integrated Management of 
Childhood Illness case deﬁ nitions).3 This approach 
enabled us to estimate the proportion of children who 
were actually admitted (appendix p 12). We assessed 
variation in incidence by case deﬁ nitions for disease 
severity and by distance from the hospital. We used 
incidence ratios to compare the diﬀ erence in incidence 
between boys and girls.
To estimate in-hospital deaths due to severe and very 
severe ALRI, we applied the meta-estimates of the 
in-hospital case-fatality ratios to incidence data for 
admissions for severe and very severe ALRI for developing 
and industrialised regions. We did a sensitivity analysis to 
assess whether the case fatality ratio was a function of the 
disease incidence and noted no such relation across the 
developing world (appendix pp 44–45). This ﬁ nding 
supports our decision to use a standard ratio (obtained 
from the random eﬀ ects model) for all developing 
countries. We did all data analysis with Stata (version 11.2).
Role of the funding source
The funding sources supported a meeting of the Severe 
ALRI Working Group in Edinburgh, UK (Aug 30–31, 
2010). The sponsor of the study had no role in study 
design, data collection, data analysis, data interpretation, 
or writing of the report. HN had full access to all the data 
in the study and HN and HC had ﬁ nal responsibility for 
the decision to submit for publication.
Results
We identiﬁ ed 89 hospital-based studies with suitable 
data for incidence (ﬁ gure 1); 61 were published7–65 (of 
which 14 were in Chinese and two9,17 had data for 
two diﬀ erent populations) and 28 were unpublished 
(ﬁ gure 2; appendix pp 17–26). 30 studies were in rural 
populations, 17 in urban populations, and 42 were in a 
mixture of both. 25 (40%) of 62 studies from developing 
countries were either cohort studies or were in a 
demographic sur veillance site; seven (11%) had a well-
deﬁ ned catchment area for which we estimated the 
population with a health-care utilisation survey, and 
30 (49%) were undertaken in hospitals with well deﬁ ned 
catchment areas. Only 43 studies (24 published and 
19 unpublished; appendix pp 7–8) reported disease 
incidence by age group for the full age range and we 
imputed data for the remaining 46 studies. 19 studies 
(15 unpublished) reported inci dence speciﬁ cally for 
neonates (infants aged 0–27 days; appendix pp 31–32). 
The 62 studies from developing countries reported 
incidence of hospital admissions for severe ALRI in 
children aged 0–59 months (about 20 episodes per 
1000 children per year; table 1).
Disease incidence was highest in neonates aged 
0–27 days (68·6 episodes per 1000 per year, 95% CI 
47·8–98·4; appendix pp 31–32) and infants aged 
0–11 months (51·8 episodes per 1000 per year, 44·8–59·8). 
With data from 27 studies in indus trialised countries, 
estimates of the incidence of admis sions for severe ALRI 
was about 20 episodes per 1000 children per year in 
children aged 0–11 months, and about 10 episodes per 
1000 children per year in those aged 0–59 months, which 
translate to about 12 million episodes worldwide in 
children younger than 5 years in 2010, with disease in 
neonates contributing to about 6% of this overall burden 
(table 1). Data from 15 unpublished studies that recorded 
this information showed that only about 60% of children 
admitted with ALRI have indrawing of the lower-chest 
wall (appendix pp 38–39). 36 studies (34 from developing 
countries) reported the incidence of admissions for very 
severe ALRI in children aged 0–59 months (appendix 
pp 27–30). We estimated that the incidence of admissions 
for very severe ALRI in this age group in developing 
countries was about ﬁ ve episodes per 1000 children per 
year, which translates to about 3 million cases worldwide 
5955 records identified from 
 database search
3678 records after duplicates
 removed
3395 records excluded because not 
 relevant to topic
7 records identified from 
 other sources
61 full-text articles reported
 incidence data
89 studies provided 
 incidence data
10 full-text articles reported
 case-fatality ratios
89 studies providing incidence 
 data for admissions for 
 severe ALRI included in the
 meta-analysis
36 studies providing incidence 
 data for admissions for 
 very severe ALRI included
 in the meta-analysis
3678 records screened
283 full-text articles 
 assessed for eligibility
28 unpublished population-based 
 studies identified for 
 supplementary data
222  full-text articles excluded 
 216 did not meet inclusion criteria 
 3 reported incidence of ALRI 
  confirmed by chest radiograph
 3 studies used 
  community–based active 
  case ascertainment
Figure 1: Flow diagram for selection of studies
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Region of the Americas
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European region
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Western Pacific region
Published studies
Unpublished data
Figure 2: Location of the 89 studies by WHO region
Africa Americas Eastern 
Mediter-
ranean
Europe South-East 
Asia
Western 
Paciﬁ c
Developing 
countries*
Industrial-
ised 
countries
Global
Severe ALRI
Aged <1 year
Studies 14 (2) 20 (1) 2 (0) 14 (9) 14 (6) 25 (15) 65 (21) 24 (12) 89 (33)
Incidence† 50·8 
(33·6–76·9)
46 
(35·5–59·7)
27·9 
(14–55·5)
14·2 
(8·1–25)
48·1 
(34·8–66·6)
43 
(32·3–57·3)
51·8 
(44·8–59·8)
19·6 
(16·1–23·9)
··
Number of episodes (thousands)‡ 1431 
(637–2167)
693 
(534–900)
428 
(215–851)
160 
(91–282)
1738 
(1257–2406)
1071 
(803–1430)
6152 
(5300–7102)
228 
(187–278)
6380 
(5508–7380)
Aged <5 years
Studies 14 (3) 20 (7) 2 (0) 14 (4) 14 (4) 25 (1) 65 (13) 24 (6) 89 (19)
Incidence† 22·6 
(15·3–33·4)
19·8 
(14·6–27)
12·1 
(8·6–17·2)
7·3 
(4·6–11·6)
17·8 
(12·2–26·1)
17·3 
(13·4–22·3)
19·7 
(17·1–22·7)
9·9 
(7·4–13·3)
··
Number of episodes (thousands)‡ 3014 
(2040–4454)
1525 
(1124–2071)
873 
(621–1241)
393 
(248–624)
3120 
(2193–4692)
2014 
(1560–2596)
11 373 
(9872–13 104)
569 
(425–764)
11 942 
(10 297–13 869)
Very severe ALRI
Aged <1 year
Studies 6 (1) 11 (0) .. .. 7 (2) 12 (7) 35 (10) 1 (0) 36 (10)
Incidence† 30·8 
(21·9–43·2)
8·6 
(5·6–13·3)
.. .. 11·5 
(5–26·4)
17·4 
(9·7–31·4)
13·7 
(10·2–18·5)
8·6 
(8·4–8·9)
··
Number of episodes (thousands)‡ 868 
(617–1217)
130 
(84–200)
.. .. 416 
(181–957)
416 
(232–751)
1627 
(1211–2197)
100 
(97–103)
1727 
(1309–2300)
Aged <5 years
Studies 6 (1) 11 (3) .. .. 7 (1) 12 (1) 36 (6) 1 (0) 36 (6)
Incidence† 15 
(10·4–21·6)
3 
(1·9–4·7)
.. .. 3·7 
(1·7–8)
6·3 
(3·5–11·2)
5·1 
(3·8–6·9)
3 
(2·9–3·1)
··
Number of episodes (thousands)‡ 1772 
(1209–2598)
179 
(89–358)
.. .. 622 
(219–1758)
729 
(407–1306)
2794 
(1980–3983)
173 
(167–178)
2967 
(2147–4162)
Data in parentheses are imputed number of studies or 95% CI. ALRI=acute lower respiratory infection. *Data include American Indian and Alaska native populations in the USA because the socioeconomic and 
demographic risk factors for ALRI in these populations are similar to those in the developing countries. †Data are incidence meta-estimates from random eﬀ ects model. ‡Number of episodes globally in 2010 is 
the sum of the episodes in children residing in developing and industrialised countries in that year.
Table 1: Estimates of incidence (per 1000 children per year) and the number of episodes of severe ALRI and very severe ALRI in children younger than 5 years admitted to hospital in 2010, 
by WHO regions
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in 2010 (table 1). We estimate that about 15% (95% CI 
10·2–20·8) of all infants and 11% (7–16·3) of children 
aged 12–59 months admitted with severe ALRI have 
hypoxaemia. However, the prevalence of hypoxaemia in 
these children is highly variable across study sites and 
regions (appendix pp 42–43).
Findings from 28 unpublished studies show that the 
incidence of admissions for severe ALRI was higher in 
boys than in girls for all age groups and regions; this sex 
diﬀ erence was greatest in studies from South Asia 
(ﬁ gure 3). We identiﬁ ed two studies that reported data for 
residence of children with the Geographic Infor mation 
System, which showed that disease incidence generally 
decreased with increasing distance from hospital, except 
at one site in which admission rates were low for children 
living within 2 km of hospital (appendix p 46).
We identiﬁ ed four unpublished studies that used both 
active community-based case ascertainment and had a 
hospital group for passive case ascertainment (appendix 
p 33). The proportion of children with chest wall in-
drawing identiﬁ ed in the community that were treated in 
hospital varied greatly between these studies (median 
proportion 0·5, IQR 0·4–0·6). We used this proportion 
and data for health-care use for ALRI from DHS and 
MICS databases to estimate that about 19 million episodes 
of severe ALRI occurred in children aged 0–59 months 
globally in 2010 (ﬁ gure 4). This preliminary estimate is 
consistent with published and well accepted incidence 
and mortality estimates and is within the conﬁ dence 
intervals of the previous global estimate (ﬁ gure 4).1,2
We sought to describe the variation in incidence of 
admissions for severe ALRI in children aged younger 
than 5 years between 2008 and 2010, mainly during the 
inﬂ uenza A H1N1 pandemic in 2009–10. Eight studies 
(see appendix pp 14–15 for study numbers U7, U9, U11, 
U17, U18, U22, U25, U26) had data for 2007–08 and 
2009–10. Overall, a 32·5% (95 % CI 31–33·9; p<0·0005) 
increase was recorded in the incidence of admissions for 
severe ALRI between 2007–08 and 2009–10. However, the 
reported individual rates varied substantially and did not 
diﬀ er in neonates. Similarly, with data from eight studies 
we noted a 40% (33–47) increase in incidence of admis-
sions for very severe ALRI, again restricted to the post-
neonatal population.
We identiﬁ ed ten published11,14,21,24,35,40,41,63,64,66 and 
27 unpub lished studies (appendix pp 34–35) providing 
data for in-hospital case fatality in children aged younger 
than 5 years admitted with severe ALRI, and 16 unpub-
lished studies (appendix p 36) reporting case fatality for 
very severe ALRI. We estimated that the hospital-based 
case-fatality ratio was 2·3% (95% CI 1·6–3·4; table 2) in 
children aged 0–59 months admitted with severe, and 
6·1% (4·6–8·1) for those with very severe ALRI in 
developing countries in 2010, with the highest rates 
reported in studies from Africa; by contrast, estimated 
case-fatality ratios in industrialised countries were 0·6% 
(0·4–0·8; table 2) and 3·9% (3·1–4·8), respectively.
We applied the in-hospital meta-estimates of case 
fatality for the developing and industrialised regions to 
the incidence meta-estimates for those regions and 
Figure 3: Incidence of admissions for severe acute lower respiratory infection in boys versus girls aged 0–59 months
Error bars show 95% CIs. Appendix pp 14–16 show details of the unpublished studies and study numbers.
Global meta-estimate
Bohol, Philippines (U28)
Regional meta-estimate (SE Asia)
Ballabgarh, Haryana, India (U27)
Multicentre, Bangladesh (U26)
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Prospects see http://esa.un.org/
unpd/wpp/unpp/panel_
population.htm
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estimated that worldwide in 2010, severe ALRI resulted 
in about 0·3 million in-hospital deaths in children aged 
0–4 years, and 67% of these deaths were in young 
children who presented with signs of very severe ALRI 
on admission (panel). The case-fatality ratio was 9% 
(95% CI 1–18) higher in girls (p=0·01) aged 0–11 months 
than in boys of this age, but did not diﬀ er signiﬁ cantly 
(p=0·49) by gender in children aged 12–59 months, in 
whom the ratio was 6% (–13 to 22) higher in boys 
(p=0·49).
Discussion
We estimated that in 2010, there were about 12 million 
episodes of hospital admissions for severe and 3 million 
for very severe ALRI. We further estimated that severe or 
very severe ALRI resulted in about 0·3 million deaths in 
hospitals in young children. 99% of these deaths were in 
developing countries, and in-hospital deaths were about 
19% (uncertainty range 12–41%, based on extreme 
combinations of numerator and denominator 95% CI 
values) of the estimated total number of ALRI deaths in 
young children in 2010. The incidence of admissions for 
severe ALRI were more than three times higher in 
neonates and about 1·3 times higher in infants aged 
0–11 months than the overall rate in young children aged 
0–59 months. Estimates are very variable within and 
between countries and regions and across diﬀ erent study 
periods (table 1, table 2, appendix pp 17–30).
Several factors aﬀ ect these estimates: method of case 
ascertainment, precise case deﬁ nitions for the various 
categories of admission, geographical location of the 
study sites, cultural factors, and health-care seeking 
behaviour of the population. Hence, the true uncertainties 
around these estimates are larger than those expressed 
in a standard 95% CI that we report. We have attempted 
to reduce these biases by using strict case deﬁ nitions and 
minimum quality criteria for included studies. Estimates 
from developing and indus trialised countries are not 
strictly comparable because case deﬁ nitions in 
developing countries tend to be based on simple clinical 
syndromic criteria, with no require ment for results of 
investigations. Health information systems in developing 
countries do not typically provide accurate information 
about the regional and national burden of severe ALRI 
on hospital services, despite this information being of 
key importance for the planning of these services. 
Therefore, such estimates could be useful in the many 
settings where data are scarce. The incidence meta-
estimate for admissions of severe ALRI in developing 
countries derives largely from studies in which the 
catchment population had fairly good access to care, and 
where study interventions might have changed health-
care seeking behaviour of participants. We recognise that 
many children with severe ALRI in developing countries 
do not receive hospital care. Therefore, our global and 
regional esti mates are likely to underestimate the true 
burden of severe ALRI, but rather show the burden of 
such infection on hospital services, with the assumption 
that the level of health-care access and use is similar to 
that in the included 89 studies.
We estimated the extent to which these hospital-based 
data underestimate the true incidence of severe ALRI in 
developing countries with poor access to and use of 
hospital care (ﬁ gure 4). Although based on indicator data 
from DHS and MICS for seeking of appropriate health 
care for children with reported signs of ALRI (rather than 
care sought for severe ALRI), our estimate of severe 
ALRI in young children receiving hospital care is broadly 
consistent with that (49%, IQR 36–62%) from the four 
hospital studies used in the second of our two analytical 
approaches.3 Furthermore, our estimates are consistent 
with those reported elsewhere (ﬁ gure 4).1,2
Estimated number of episodes 
of severe ALRI worldwide in 
children <5 years in 2000
13·1 million (95% CI 
10·1–19·6 million)2 
Estimated (severe) ALRI deaths
in children <5 years in 2010
1·40 million (1·19–1·64 million)1 
Estimated number of episodes 
of severe ALRI worldwide in 
children <5 years in 2010
19·2 million (15·6–23·8 million) 
62% of cases that 
reach hospitals 
11·9 million (10·3–13·9)
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in admitted cases 
2·1% (1·4–3·1)
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19% of deaths were 
in hospital 
0·27 million (0·16–0·45)
38% of cases do not 
reach hospitals 
7·3 million (5·3–9·9)
Case-fatality ratio
in communities 
15·4% (10·4–22·5)
81% of deaths occur
outside hospital 
1·13 million (1·03–1·19)
Figure 4: Global burden of severe acute lower respiratory infection, including 
burden on hospital services
Understanding how these estimates ﬁ t with previously reported estimates of the 
global burden of acute lower respiratory infection (ALRI) is relevant for 
development of health policies for control of disease mortality. The dark green 
boxes show previously reported estimates of the global burden of severe ALRI 
(based on 28 community-based studies of ALRI morbidity) and the burden of 
ALRI-related deaths (based on independent data that combined vital registration 
data and data from multicause mortality studies, mainly with verbal autopsy) in 
young children. Our study (white boxes), based on data from hospital-based 
studies, introduces a health systems perspective to these previous estimates, 
which were based mainly on community based studies. We used the estimate for 
admissions of severe ALRI and available information about health facility use in 
diﬀ erent global regions to derive an estimate of the possible cases of severe ALRI 
in the community (orange boxes). The grey boxes show the burden of childhood 
cases of severe ALRI not accessing hospital inpatient services.
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The high number of severe ALRI episodes mostly 
shows inadequate care-seeking behaviour or poor access 
to hospital care, or both, in some settings. For example, 
many children referred for hospital care do not attend 
because of cost or cultural factors.67 This estimate also 
shows the extent of the large referral burden on hospital 
services in developing countries, which suggests a need 
for substantially increased investment in hospital capacity 
for inpatient and outpatient services, both in terms of 
human resources and for provision of relevant drugs and 
supplies for paediatric care. New approaches to increasing 
of treat ment coverage for severe pneu monia, as deﬁ ned 
by WHO, in communities that are underserved by 
hospitals have been eﬀ ective in Asian settings.68,69 WHO 
recom mendations, based on ﬁ ndings from these 
controlled trials in Asia70 for management of cases of 
WHO severe pneumonia with oral antibiotics at home is 
one strategy that could be eﬀ ective in some settings.
The analysis in ﬁ gure 4 shows a general consistency 
in estimates and has important policy implications: 
although 62% of children manage to reach hospitals, 
most deaths still take place outside hospitals. This result 
is attributable to the large diﬀ erence in case fatality 
between hospital-treated and non-hospital-treated severe 
ALRI. Furthermore, the ﬁ ndings suggest that even if very 
high rates of access and care seeking were achieved, the 
number of deaths might still be high. In addition to 
strategies to increase coverage of pnemococcal vaccin-
ation in young children, scaling up of community case 
management of childhood ALRI (including management 
of WHO severe pneumonia when appropriate) should be 
regarded as an eﬀ ective strategy that could help to reduce 
the remaining burden of mortality, remove the burden 
on hospital services, and improve equity in reduction of 
child mortality.
Findings from two studies (appendix p 46) showing 
that incidence of admissions for severe ALRI de creased 
with increasing distance from the hospital were 
consistent with previous reports71,72 and emphasise that 
access to hospital care is an important determinant of 
deaths from pneumonia in children in developing 
countries. We noted a consistently higher incidence of 
admissions for severe ALRI in boys than in girls. 
Although this increased risk could be attributable to the 
smaller airway size in young boys than in young girls,73 
the substantially height ened sex diﬀ erences in South 
Asian studies (India, Pakistan, and Bangladesh) probably 
shows the importance of cultural factors, such as pref-
erence in seeking medical care for boys.74,75 Global burden 
of disease estimates tend not to include estimates by sex 
for child mortality from pneumonia; therefore, to what 
extent sex diﬀ erences aﬀ ect pneumonia mortality is 
uncertain. These diﬀ er ences, especially those in South 
Asia, merit further study and programmatic attention 
because they could represent substantial health inequity. 
Investigators of future epi demi ological studies should 
make increased eﬀ orts to gather, analyse, and report 
gender-speciﬁ c data to increase the attention given to this 
important issue.
Hypoxaemia is a key predictor of ALRI mortality76 and 
an important indicator of severity. Hypoxaemia preva-
lence estimates were variable across study sites and 
deﬁ ned by factors such as altitude of the study site. 
12·6% of severe cases had hypoxaemia, which is 
consistent with ﬁ ndings from a systematic review and 
meta-analysis.76 Our estimates suggest that every year 
about 1·5 million children admitted with severe ALRI 
need oxygen treat ment. The estimates further emphasise 
and quantify the need for pulse oximetry equipment and 
related staﬀ  training for identiﬁ cation of children with 
Aged 0–11 months Aged 12–59 months Aged 0–59 months
Studies CFR (%) Studies CFR (%) Studies CFR (%)
Africa 9 3·8% (2·4–5·9) 8 1·9% (1·2–3·2) 11 3·9% (2·7–5·5)
Americas 10 1·6% (1·1–2·4) 10 0·6% (0·2–1·3) 11 1·3% (0·8–1·9)
Eastern Mediterranean 1 9·9% (8·6–11·5) ·· ·· 2 7·6% (4·1–13·9)
Europe ·· ·· ·· ·· 1 0·4% (0·3–0·5)
Southeast Asia 6 2·6% (1·4–4·7) 4 0·3% (0·1–0·9) 9 2·1% (1·1–4)
Western Paciﬁ c 1 2·4% (1·3–4·3) ·· ·· 3 2·3% (1·7–3·2)
Developing 26 2·4% (1·7–3·6) 21 0·8% (0·4–1·3) 34 2·3% (1·6–3·4)
Industrialised 1 0·8% (0·7–0·9) 1 0·3% (0·2–0·5) 3 0·6% (0·4–0·8)
Global 27 2·3% (1·5–3·4) 22 0·7% (0·4–1·2) 37 2·1% (1·4–3·1)
Data in parentheses are 95% CI. CFR=case-fatality ratio.
Table 2: Case-fatality ratio due to severe acute lower respiratory infections in children younger than 
5 years who were admitted, by region
Panel: Estimated new cases per year, case-fatality ratio, and mortality in children 
younger than 5 years admitted to hospital for severe acute lower respiratory 
infections (ALRI)
Children admitted for severe ALRI
a Estimated new cases per year in developing countries: 11 372 600 (95% CI 
9 871 650–13 104 470)
b Estimated case-fatality ratio in developing countries: 2·3% (1·6–3·4)
c Estimated mortality in hospitals in developing countries: a×b=261 570 
(157 950–445 550)
d Estimated new cases per year in industrialised countries: 569 020 (425 330–764 440)
e Estimated case-fatality ratio in industrialised countries: 0·6% (0·4–0·8)
f Estimated mortality in hospitals in industrialised countries: d×e=3410 (1700–6120)
g Estimated global mortality: c+f=264 980 (159 650–451 670)
Children admitted for very severe ALRI
h Estimated new cases per year in developing countries: 2 794 080 
(1 980 100–3 983 300)
i Estimated case-fatality ratio in developing countries: 6·1% (4·6–8·1)
j Estimated mortality in hospitals in developing countries: h×i=170 440 
(91 090–322 650)
k Estimated new cases per year in industrialised countries: 172 430 (166 680–178 180)
l Estimated case-fatality ratio in industrialised countries: 3·9% (3·1–4·8)
m Estimated mortality in hospitals in industrialised countries: k×l=6730 (5170–8550)
n Estimated global mortality: j+m=177 170 (96 260–331 200)
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hypoxaemia, because clinical signs are poor indicators of 
this complication.76
We estimate that about a third of all admissions 
for severe ALRI meet clinical criteria for very severe 
ALRI and need second-line parenteral treatment with 
antibiotics; however, substantial heterogeneity exists. In 
general, the incidence estimates for African countries are 
about ﬁ ve times higher than those for other developing 
regions. This ﬁ nding could show poor access to care in 
these regions, leading to delays in antibiotics and 
frequent progression to more severe disease. Further-
more, the estimates are consistent with severe falciparum 
malaria in endemic areas being misclassiﬁ ed as severe 
ALRI in settings with few diagnostic facilities.77
In 2010, during the inﬂ uenza A H1N1 pandemic, our 
estimates showed an increase in the incidence of 
admissions for severe and very severe ALRI com pared 
with estimates from the same sites for 2008. This ﬁ nding 
could result from increased community aware ness about 
respiratory illness during the pandemic period, leading to 
increased care seeking and hospital admission or because 
of an annual variation in the incidence of severe ALRI. 
However, the increase in admission could be partly 
explained by disease due to the pandemic predisposing to 
subsequent bacterial pneumonias.78 This relation needs to 
be investigated because the ability of health services to 
respond to a substantial increase in childhood severe 
ALRI could be an important component of pandemic 
inﬂ uenza preparedness and for reducing of inﬂ uenza-
related childhood mortality.
No data are available for several regions worldwide 
with large high-burden populations79—eg, WHO’s 
Eastern Mediterranean region and much of sub-Saharan 
Africa. Our estimates of the incidence of admissions for 
severe ALRI could be used to assess the needs for 
equipment, such as pulse oximeters and oxygen con-
centrators, and for drugs in hospitals in developing 
countries where health information systems cannot 
supply these data. The fairly low estimated percentage of 
overall deaths that take place in hospital emphasises that 
access to hospital care is inadequate in many developing 
countries. Investment should be made to improve such 
access and to introduce new strategies, such as com-
munity case management for cases presently classiﬁ ed 
as WHO severe pneumonia. Access to care, sex inequities 
in care seeking, and appropriate case management of 
children with severe and very severe pneumonia needs 
urgent assessment if further reductions in childhood 
deaths from pneumonia are to be achieved.
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